1 / 6
Laboratory Research Material
GLOW
70 mg per vial · Lyophilized powder
Laboratory Research Material
GLOW 70 mg per vial
$169.99
- Blend composition
-
Compound Per vial GHK-Cu 50 mg TB-500 10 mg BPC-157 10 mg Total per vial 70 mg - Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.
Product Documentation
Details, specifications, and documents
Description
GLOW 70 mg peptide blend
Buy GLOW peptide blend 70 mg for laboratory research. Each boxed 3 mL vial contains lyophilized powder with three labeled components: GHK-Cu 50 mg, TB-500 10 mg and BPC-157 10 mg.
- GHK-Cu: 50 mg per vial
- TB-500: 10 mg per vial
- BPC-157: 10 mg per vial
- Total blend: 70 mg per vial
The GHK-Cu component is the peptide-copper complex identified by CAS 89030-95-5. The TB-500 component is full-length, N-acetylated thymosin beta-4: a 43-amino-acid peptide identified by CAS 77591-33-4.
GLOW composition and product choice
GLOW contains three ingredients. The KLOW 80 mg blend includes the same labeled amounts plus 10 mg of KPV. The names are not interchangeable, so compare the component list rather than choosing by the total milligrams alone.
The 50 mg GHK-Cu amount describes the complete peptide-copper complex, including copper. It is not 50 mg of copper alone or copper-free GHK. A premixed vial also fixes the ingredient proportions. If a study needs a separate copper-peptide control, the GHK-Cu product is a different presentation to consider.
What the component studies show
Maquart and colleagues reported increased collagen synthesis in fibroblast cultures exposed to GHK-Cu, independently of changes in cell number. That result describes the copper-peptide complex in a cell model.
BPC-157 experiments examined migration in rat-derived tendon cells. TB-500 analytical research identified an acetylated seven-residue fragment in a different preparation. That study does not characterize this blend’s full-length TB-500 component.
The cited studies used individual materials and different experimental systems. They do not demonstrate synergy or predict the performance of this three-component mixture. Compare the complete formulation with appropriate component controls when interpreting results.
Certificate of analysis and product documentation
Open COA & Documents to review the available batch records. Match the lot and formulation, then check which components were identified and whether their amounts were measured separately. Purity, identity and component content answer different questions; one percentage cannot stand in for all three.
Use the supplied chemical forms for molecular calculations and the mixture’s documentation for handling and storage. The 3 mL figure describes vial capacity, not liquid supplied or a preparation volume.
Additional information
| CAS No. | GHK-Cu: 89030-95-5, TB-500: 77591-33-4, BPC-157: 137525-51-0 |
|---|---|
| Purity | ≥99% |
| Synthesis Method | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Water or validated laboratory buffer |
| Stability & Storage | Follow the product label and applicable laboratory storage procedure. A fixed shelf life is not specified here. |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Appearance | See lot-specific documentation |
| Regulatory/Compliance | Not for human consumption. For research use only. |
| Safety Information | See COA & Documents for available product records and handling guidance. |
COA & Documents
Independent lot testing
GLOW 70mg Certificate of Analysis
This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.
- Lot number
- 99723
- Report number
- IF-824-QSA-TR006-BTL26955-13
- Date tested
- July 15, 2026
- Reported purity
- 99.7%
- Labeled content
- 70 mg
Product documents
Product information and laboratory resources. For lot-specific results, use the COA above.
Product & packaging information
Labeled amount, physical form and packaging for GLOW 70mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Contact our support team for help with product records, lot information, orders or certificate verification.
